According to the announcement by the Board of Directors of basetrophy gp (08460) on the record date, the total number of shares issued is 115 million shares. The total number of shares offered for subscription and sale in accordance with the rights issue is 345 million shares. The Board of Directors announced that, as of June 21, 2024 (Friday) at 4:00 pm local time (ie, the final acceptance deadline), a total of four valid applications were received and accepted based on the provisional allocation, subscribing to a total of 30.74 million shares of shares for sale, accounting for approximately 8.91% of the sale shares available for subscription under the rights issue.

The remaining 314 million shares of unsubscribed shares for sale, accounting for approximately 91.09% of the total sale shares available for subscription under the rights issue, will be subject to compensation arrangements.